Filament Health Corp. announced a non-brokered private placement to issue minimum of 6,666,667 units and maximum of 13,333,333 units at an issue price of CAD 0.15 for the minimum gross proceeds of CAD 1,000,000.05 and maximum of CAD 1,999,999.95 on September 29, 2023. Each unit will consist of one common share and one common share purchase warrant.

Each warrant will be exercisable to acquire one common share for a period of 36 months following the closing date of the offering at an exercise price of CAD 0.20 cents, representing a 33% premium to the issue price, or other amount approved by the Neo Exchange. The transaction was led by returning investor Negev Capital. The transaction is subject to regulatory approval.